Japanese Pharma Giant Leases Entire 600K SF Lab Project In Kendall Square

Takeda Pharmaceuticals signed a full building lease at 585 Kendall in Cambridge.
Takeda Pharmaceuticals Signed A Full-Building Lease At 585 Kendall In Cambridge.

Takeda Pharmaceuticals, a Japanese drug manufacturer, signed a full-building lease for a new BioMed Realty development in Kendall Square.

The 16-story project at 585 Third St., branded as 585 Kendall, is slated to feature 600K SF of research and development space. BioMed, which announced the lease Wednesday morning, expects to complete the project in 2026.

BioMed acquired the 1-acre property for $50.5M in 2018. Along with the lab building, the project is also planned to include a new 300-seat performing arts venue. Additionally, the developer has committed to relocate a gas transfer station on Third Street.

“Rapid technological and medical innovation has led to continued demand for well-designed, mission critical life sciences research space concentrated in leading markets like Cambridge," BioMed President Bill Kane said in a release. "This significant lease is proof of the growing need for essential infrastructure that enhances collaboration and helps advance vaccine and drug discovery."

Takeda also plans to take two more floors in a nearby building it occupies at 650 East Kendall St., the Boston Business Journal reported. The firm plans to transition teams away from several offices it leases in Central Square, but it said it will maintain its presence in Lexington.

CBRE represented BioMed Realty and Cushman & Wakefield represented Takeda in the deal. CBT Architects designed the lab and office space.

A subsidiary of Blackstone, BioMed has rapidly expanded throughout the state's most successful life sciences cluster. It has grown its portfolio to at least 25 properties in Cambridge, according to its website.

This deal is BioMed's second Boston-area leasing win in as many weeks. Last week, the company revealed five new leases were signed at its nearly completed South End lab project.

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's Boston Newsletters
Related Stories

Philly Life Sciences Players Say Sluggish Market Needs More VC, State Funding

Developer Plans 595 Apartments At Woburn Transit Center

Boston City Council Votes To Eliminate Parking Minimums For New Housing Development

Lack Of Available Medical Office Space In Boston Forces Tenants To Get Creative

Fenway Center Apartment Complex Trades For $193M: The Boston Deal Sheet

How The Investors Upgrading Boston's Old Office Towers Are Luring New Tenants

AI Helps Drive New Demand For Lab Buildings, But Property Values Remain 'Depressed'

Lender Takes Control Of Vacant Somerville Lab Building Following Failed Sale

Kraft Group Seeks To Build $16B Data Center Campus: The Boston Deal Sheet

Wu Proposes Loosening Affordable Housing Mandates To Spur Development

Revere Housing Authority Seeks Zoning Change For 1,700-Unit Redevelopment

Raleigh-Durham's Growth Story Is Moving Beyond Life Sciences